Analytical Core Unit

分析核心单元

基本信息

  • 批准号:
    8690955
  • 负责人:
  • 金额:
    $ 31.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
    至 2015-12-31
  • 项目状态:
    已结题

项目摘要

Throughout the Program, the delivery of genes to promote or disrupt biological process is integral to the prosecution of the aims outlined in all of the 4 projects. The production of purified recombinant proteins will facilitate the identification of novel post-translational mechanisms (Projects 1 and 4) and analysis of protein: protein interactions (Project 2). The measurement of reactive oxygen and reactive nitrogen species (superoxide, hydrogen peroxide and nitric oxide) is necessary to correlate changes in the levels of these metabolites to their biological effects (Projects1-4). Cellular imaging VJ\\\ provide new perspectives into the regulation of protein subcellular localization and co-localization (Projects 2-4). These services are best centralized given their inherent difficulty, reliance on specialized equipment and expertise and proposed use by more than 2 of the 4 projects. To accomplish these goals, we propose the following specific aims: Specific Aim 1 - Gene Delivery: The goals of this aim are to construct, purify and deliver recombinant adenovirus and lentivirus expressing genes and small inhibitory RNAs and also to synthesize large quantities of endotoxin-free plasmid DNA for the electroporation of tissues in vivo. Specific Aim 2 - Analysis: The goals of this aim are a) to synthesize recombinant proteins for th direct analysis of post-translational modifications and enzymatic activity b) to provide uniform measurements of reactive oxygen and nitrogen species and c) to determine the subcellular localization of and identify protein- colocalization inside cells. These services will be overseen by Dr. Fulton (Core Leader) who has considerable experience with the production and delivery of recombinant viruses and analysis of reactive nitrogen species and by Dr. Black (co-core leader) who is an expert in the expression and purification of proteins, the use of EPR technology to measure ROS levels in purified protein, cell culture, and whole animals. RELEVANCE (See Instructions): The overall goal of this Core is to provide a centralized service that facilitates the delivery of genes via recombinant virus and electroporation, provides standardized measurements of reactive nitrogen and reactive oxygen species in biological fluids, generates large quantities of recombinant proteins and state of the art cellular imaging.
在整个计划中,传递基因以促进或破坏生物过程是不可或缺的, 实现所有4个项目中概述的目标。纯化的重组蛋白的生产将 促进新的翻译后机制的鉴定(项目1和4)和蛋白质的分析: 蛋白质相互作用(项目2)。活性氧和活性氮的测定 (超氧化物、过氧化氢和一氧化氮)对于将这些物质水平的变化联系起来是必要的 代谢物的生物学效应(项目1 -4)。细胞成像VJ\提供了新的视角, 蛋白质亚细胞定位和共定位的调节(项目2-4)。这些服务是最好的 鉴于其固有的困难、对专门设备和专门知识的依赖以及拟议的用途, 4个项目中的2个以上。为实现这些目标,我们提出以下具体目标: 具体目标1 -基因递送:本目标的目标是构建、纯化和递送重组 腺病毒和慢病毒表达基因和小的抑制性RNA, 用于体内组织电穿孔的无内毒素质粒DNA。 具体目标2 -分析:该目标的目标是a)合成用于直接分析的重组蛋白, 分析翻译后修饰和酶活性B)以提供以下的统一测量: 活性氧和氮类和c)确定蛋白质的亚细胞定位和鉴定蛋白质- 细胞内的共定位这些服务将由富尔顿博士(核心负责人)监督, 在重组病毒的生产和交付以及反应性分析方面具有丰富的经验, 氮物种和博士布莱克(共同核心领导人),谁是在表达和纯化的专家, 蛋白质,使用EPR技术来测量纯化蛋白质,细胞培养物和整个细胞中的ROS水平。 动物 相关性(见说明): 这个核心的总体目标是提供一个集中的服务,促进基因的交付,通过 重组病毒和电穿孔,提供了活性氮的标准化测量, 生物体液中的活性氧,产生大量的重组蛋白和 细胞成像技术。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen M Black其他文献

Increased NADPH Oxidase Derived Superoxide is Involved in Hypoxia Ischemic Neuronal Cell Death in Neonatal Hippocampal Slice Cultures
  • DOI:
    10.1016/j.freeradbiomed.2010.10.440
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Qing Lu;Valerie Harris;Yali Hou;Thomas Rau;Jing Tian;David J Poulsen;Stephen M Black
  • 通讯作者:
    Stephen M Black
Endothelin-1 in Congenital Heart Disease
内皮素-1 在先天性心脏病中
  • DOI:
    10.1203/01.pdr.0000160447.83332.13
  • 发表时间:
    2005-05-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Maurice Beghetti;Stephen M Black;Jeffrey R Fineman
  • 通讯作者:
    Jeffrey R Fineman
206 - Targeted Protein Protection from Oxidative/ Nitrosative Post-Translational Modifications Using Shielding Peptides
  • DOI:
    10.1016/j.freeradbiomed.2015.10.250
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Olga Rafikova;Stephen M Black;Ruslan Rafikov
  • 通讯作者:
    Ruslan Rafikov
The Rebound Pulmonary Hypertension Associated with the Acute Withdrawal of Inhaled Nitric Oxide involves the Nitration-Mediated Inhibition of Protein Kinase G: Protective Role of Superoxide Dismutase
  • DOI:
    10.1016/j.freeradbiomed.2010.10.002
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Saurabh Aggarwal;Christine M Gross;Sanjiv Kumar;Peter Oishi;Jeffrey R Fineman;Stephen M Black
  • 通讯作者:
    Stephen M Black
Nitration-mediated Activation of RhoA: Its Role in LPS-induced Endothelial Barrier Dysfunction
  • DOI:
    10.1016/j.freeradbiomed.2010.10.106
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ruslan Rafikov;Saurabh Aggarwal;Christine Gross;Sanjiv Kumar;Yali Hou;Connie Snead;Agnieszka Jezierska;Alexander D Verin;David Fulton;John Catravas;Stephen M Black
  • 通讯作者:
    Stephen M Black

Stephen M Black的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen M Black', 18)}}的其他基金

7985-001 (Project 1)
7985-001(项目1)
  • 批准号:
    10583117
  • 财政年份:
    2022
  • 资助金额:
    $ 31.96万
  • 项目类别:
Core-001
核心001
  • 批准号:
    10524416
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Core-003
核心003
  • 批准号:
    10524650
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Admin-Core-001
管理核心-001
  • 批准号:
    10524415
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Project-003
项目-003
  • 批准号:
    10524653
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Core-003
核心003
  • 批准号:
    10533369
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator Induced Lung Injury (VILI)
遗传学、表观遗传学和翻译后修饰以及呼吸机所致肺损伤 (VILI) 的发生
  • 批准号:
    10455906
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Core-004
核心004
  • 批准号:
    10533370
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Project-003
项目-003
  • 批准号:
    10533373
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Project-002
项目-002
  • 批准号:
    10524652
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 31.96万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 31.96万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 31.96万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了